Genetic and functional characterization of disease associations explains comorbidity

dc.contributor.authorRubio Perez, Carlota
dc.contributor.authorGuney, Emre
dc.contributor.authorAguilar, Daniel
dc.contributor.authorPiñero, Janet
dc.contributor.authorGarcía García, Javier
dc.contributor.authorIadarola, Barbara
dc.contributor.authorSanz, Ferran
dc.contributor.authorFernandez Fuentes, Narcís
dc.contributor.authorFurlong, Laura I.
dc.contributor.authorOliva Miguel, Baldomero
dc.date.accessioned2017-09-19T09:27:23Z
dc.date.available2017-09-19T09:27:23Z
dc.date.issued2017-07-24
dc.date.updated2017-08-02T18:00:07Z
dc.description.abstractUnderstanding relationships between diseases, such as comorbidities, has important socio-economic implications, ranging from clinical study design to health care planning. Most studies characterize disease comorbidity using shared genetic origins, ignoring pathway-based commonalities between diseases. In this study, we define the disease pathways using an interactome-based extension of known disease-genes and introduce several measures of functional overlap. The analysis reveals 206 significant links among 94 diseases, giving rise to a highly clustered disease association network. We observe that around 95% of the links in the disease network, though not identified by genetic overlap, are discovered by functional overlap. This disease network portraits rheumatoid arthritis, asthma, atherosclerosis, pulmonary diseases and Crohn's disease as hubs and thus pointing to common inflammatory processes underlying disease pathophysiology. We identify several described associations such as the inverse comorbidity relationship between Alzheimer's disease and neoplasms. Furthermore, we investigate the disruptions in protein interactions by mapping mutations onto the domains involved in the interaction, suggesting hypotheses on the causal link between diseases. Finally, we provide several proof-of-principle examples in which we model the effect of the mutation and the change of the association strength, which could explain the observed comorbidity between diseases caused by the same genetic alterations.
dc.format.extent14 p.
dc.format.mimetypeapplication/pdf
dc.identifier.issn2045-2322
dc.identifier.pmid28740175
dc.identifier.urihttps://hdl.handle.net/2445/115597
dc.language.isoeng
dc.publisherNature Publishing Group
dc.relation.isformatofReproducció del document publicat a: http://dx.doi.org/10.1038/s41598-017-04939-4
dc.relation.ispartofScientific Reports, 2017, vol. 7, num. 1, p. 6207
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/634143/EU//MedBioinformatics
dc.relation.urihttp://dx.doi.org/10.1038/s41598-017-04939-4
dc.rightscc by (c) Rubio et al., 2017
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceArticles publicats en revistes (ISGlobal)
dc.subject.classificationComorbiditat
dc.subject.classificationGenètica humana
dc.subject.otherComorbidity
dc.subject.otherHuman genetics
dc.titleGenetic and functional characterization of disease associations explains comorbidity
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
rubio-perez2017_2647.pdf
Mida:
3.43 MB
Format:
Adobe Portable Document Format